Published in J Neurochem on June 01, 1976
Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis (2009) 1.10
Cerebral protein synthesis in a genetic mouse model of phenylketonuria. Proc Natl Acad Sci U S A (2000) 1.09
The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem J (1982) 0.90
The effects of hyperphenylalaninaemia on the concentrations of aminoacyl-transfer ribonucleic acid in vivo. A mechanism for the inhibition of neural protein synthesis by phenylalanine. Biochem J (1977) 0.87
Hypothermia-inducing peptide promotes recovery of vesicular stomatitis virus from persistent animal infections. J Virol (1985) 0.82
Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. J Inherit Metab Dis (2010) 0.77
Effects of p-chlorophenylalanine and alpha-methylphenylalanine on amino acid uptake and protein synthesis in mouse neuroblastoma cells. Biochem J (1978) 0.77
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol (1985) 5.73
Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98
Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol (1985) 1.82
Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol (1984) 1.78
High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum Gene Ther (1998) 1.68
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57
Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science (1999) 1.57
Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Infect Immun (1976) 1.53
An NADP/thioredoxin system in leaves: purification and characterization of NADP-thioredoxin reductase and thioredoxin h from spinach. Arch Biochem Biophys (1988) 1.48
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther (2000) 1.32
Vaginal douching in teenagers attending a family planning clinic. J Adolesc Health Care (1989) 1.17
A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther (1999) 1.16
Contrasting modes of photosynthetic enzyme regulation in oxygenic and anoxygenic prokaryotes. Arch Microbiol (1984) 1.14
Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate. J Virol (1979) 1.09
The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. J Viral Hepat (2005) 1.08
Synthesis and turnover of plasma-membrane proteins and glycoproteins in a neuroblastoma cell line. Biochem J (1976) 1.08
Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol (1998) 1.06
Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy (1997) 1.06
The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus. J Gen Virol (1977) 1.03
An ultrastructural study of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Lab Invest (1976) 1.03
Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus. Br J Exp Pathol (1976) 1.02
An inactivated hepatitis A viral vaccine of cell culture origin. J Med Virol (1986) 0.99
Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J Immunol (1999) 0.98
Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization. J Med Chem (1995) 0.97
Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2006) 0.96
Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2001) 0.95
Thioredoxin system of the photosynthetic anaerobe Chromatium vinosum. J Bacteriol (1984) 0.95
Regulation of protein synthesis in developing mouse brain tissue. Alteration in ribosomal activity. J Biol Chem (1970) 0.95
The mechanism of polyribosome disaggregation in brain tissue by phenylalanine. Biochem J (1975) 0.94
Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons. Infect Immun (1979) 0.92
Infection of the central nervous system produced by mixtures of defective-interfering particles and wild-type vesicular stomatitis virus in mice. J Infect Dis (1977) 0.92
Characterization of cell-surface glycopeptides from mouse cerebral cortex that inhibit cell growth and protein synthesis. Biochem J (1980) 0.91
In vivo assembly and maturation of vesicular stomatitis virus. Lab Invest (1976) 0.90
Inhibition of protein synthesis in noninfected L cells by partially purified interferon preparations. J Cell Biol (1968) 0.90
The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids. Biochem J (1982) 0.90
Ganglioside GM1 sensitizes tumor cells to growth inhibitory glycopeptides. Biochem Biophys Res Commun (1982) 0.90
Experimentally induced and natural recovery from the effects of phenylalanine on brain protein synthesis. Biochim Biophys Acta (1978) 0.88
The effects of maturation on in vitro protein synthesis by mouse brain cells. J Neurochem (1966) 0.88
Virus-induced demyelination. Production by a viral temperature-sensitive mutant. J Neurol Sci (1979) 0.88
The effects of hyperphenylalaninaemia on the concentrations of aminoacyl-transfer ribonucleic acid in vivo. A mechanism for the inhibition of neural protein synthesis by phenylalanine. Biochem J (1977) 0.87
Isolation of the glycoprotein of vesicular stomatitis virus and its binding to cell surfaces. J Gen Virol (1980) 0.87
Synthesis of RNA-polyadenylic acid by isolated brain nuclei. Science (1973) 0.87
The degradation and turnover of fucosylated glycoproteins in the plasma membrane of a neuroblastoma-cell line. Biochem J (1977) 0.87
Cell-free protein synthesis by mouse brain during early development. J Neurochem (1968) 0.87
Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method. J Pharm Biomed Anal (1996) 0.87
Glycopeptides from brain inhibit rates of polypeptide chain elongation. J Biol Chem (1980) 0.86
Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol Ther (2000) 0.86
Mass spectrometrically derived amino acid sequence of thioredoxin from Chlorobium, an evolutionarily prominent photosynthetic bacterium. J Biol Chem (1987) 0.86
Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions. J Virol (2000) 0.85
Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses. J Virol (1985) 0.85
Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1979) 0.85
Hyperphenylalanemia: effect on brain polyribosomes can be partially reversed by other amino acids. Science (1977) 0.85
Biology of E1-deleted adenovirus vectors in nonhuman primate muscle. J Virol (2001) 0.85
Regulation of protein synthesis during postnatal maturation of the brain. J Neurochem (1976) 0.84
Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine. J Gen Virol (1982) 0.84
Isolation of cell-surface glycopeptides from bovine cerebral cortex that inhibit cell growth and protein synthesis in normal but not in transformed cells. Biochem J (1982) 0.84
Affinity labeling of the sialoglycopeptide antimitogen receptor. J Biol Chem (1987) 0.84
Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. II. Immunofluorescent, morphologic, and immunologic studies. J Infect Dis (1979) 0.83
Purification and stability characterization of a cell regulatory sialoglycopeptide inhibitor. J Cell Biochem (1995) 0.83
Maturation-dependent events related to DNA-dependent RNA synthesis in intact mouse brain nuclei. Brain Res (1972) 0.83
The role of ribosomal ribonucleic acid in the structure and function of mammalian brain ribosomes. Biochem J (1974) 0.83
Alterations in peptide structure of vesicular stomatitis virus mutant and its central nervous system isolate. J Gen Virol (1981) 0.83
The effect of ribonuclease on ribosomal RNA and subsequent polypeptide synthesis. Biochem Biophys Res Commun (1973) 0.83
Effect of alpha-methylphenylalanine and phenylalanine on brain polyribosomes and protein synthesis. J Neurochem (1981) 0.83
The influence of advanced age on the outcome of assisted reproduction. J Assist Reprod Genet (1998) 0.82
Hypothermia-inducing peptide promotes recovery of vesicular stomatitis virus from persistent animal infections. J Virol (1985) 0.82
Growth and metabolism of fucosylated plasma-membrane glycoproteins in mouse neuroblastoma N2a cells. Biochem J (1978) 0.82
Prevalence of seropositive reactions to Brucella canis in a limited survey of domestic cats. J Am Vet Med Assoc (1977) 0.82
Subacute infection with temperature-sensitive vesicular stomatitis virus mutant G41 in the central nervous system of mice. I. Clinical and virologic studies. J Infect Dis (1979) 0.82
Incentives and their influence on appointment compliance in a teenage family-planning clinic. J Adolesc Health Care (1990) 0.82
Abnormal amino acid metabolism and brain protein synthesis during neural development. Neurochem Res (1978) 0.81
Glycopeptides prepared from mouse cerebrum inhibit protein synthesis and cell division in baby hamster kidney cells, but not in their polyoma virus-transformed analogs. Exp Cell Res (1981) 0.81
Temporal relationship between virus and interferon biosynthesis in L cells infected with Newcastle disease virus. Proc Soc Exp Biol Med (1969) 0.81
Developmental alterations in RNA synthesis in isolated mouse brain nucleoli. Biochim Biophys Acta (1973) 0.81
Allograft safety: viral inactivation with bone demineralization. Contemp Orthop (1995) 0.81
A cell surface glycoprotein virus inhibitor that is not interferon. Biochem Biophys Res Commun (1981) 0.81
Level and amino acid acceptor activity of mouse brain tRNA during neural development. J Neurochem (1973) 0.80
The effects of maturation on in vitro RNA synthesis by mouse brain cells. J Neurochem (1967) 0.80
Characteristics and products of a cell-free polypeptide synthesizing system from neonatal and adult mouse brain. J Neurochem (1972) 0.80
An immune cell population that responds to beta-endorphin and is responsible for protecting nude mice from the fatal consequences of a virus infection of the central nervous system. J Neuroimmunol (1991) 0.80
Mouse brain ribosomal subunits: role of ribosome-associated factors on aminoacyl-tRNA binding and polypeptide synthesis. Brain Res (1973) 0.80
Beta-endorphin alters the course of central nervous system disease induced by a temperature-sensitive vesicular stomatitis virus in reconstituted nude mice. J Neuroimmunol (1990) 0.79
Stimulation of RNA synthesis in isolated mouse brain nuclei by a brain cytosol factor. Life Sci (1974) 0.79
Purification and characterization of a cytostatic factor with anti-viral activity from the bitter melon. Prep Biochem (1983) 0.79
Aminoacyl-RNA synthetase and transfer RNA binding activity during early mammalian brain development. J Neurochem (1969) 0.79
Regulation of protein synthesis in developing mouse brain tissue: in vitro binding of template RNA to brain ribosomes. J Neurochem (1971) 0.79
Tantalum air-interspace crossed grid: design and performance characteristics. Radiology (1982) 0.79
Virus protein assembly in microgravity. Adv Space Res (1993) 0.79
Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy. Hum Gene Ther (1999) 0.78